Pronota this week launched the MASSterclass platform for biomarker verification. The platform incorporates a novel series of orthogonal complexity reduction combined with targeted mass spectrometry. Throughput is maintained when screening large panels of biomarker candidates by multiplexing different analytes in the same assay, the company said in a statement. MASSterclass complements Pronota’s MASStermind biomarker discovery platform.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.